Introduction
Prof. Andreas Hartkopf (DE), Dr. Tal Sella (IL), and Prof. Valentina Guarneri (IT), with Prof. Qiang Liu (Chair session 1) and Monique Coersmeyer (Chair sessions 2 and 3) will participate in the meeting to discuss Optimising Treatment Approaches for HR+, HER2- EBC. The panel discussion will cover identifying patients who are at high-risk of recurrence, different treatment approaches and insights into the management of side effects to improve adherence.
Objectives
• Share data on the latest data for abemaciclib for patients with HR+ HER2-breast cancer in the EBC and MBC setting and discuss the impact of this data in clinical practice. It will be an expert MDT discussion on the identification of high-risk HR+/HER2- EBC and MBC and includes; Multidisciplinary In-Depth Insights, EBC Patient Case Study, MBC Patient Case Study, Panel Discussions and Live Q&A
This Course For :
Physician
( Oncology )
Resident / Fellow
( Oncology )
Speaker
Moique Coersmeyer PhD | Switzerland
Lilly International Medical Lead Breast Cancer, PhD in cancer research and pathogenic cell signaling from Swiss Institute for Experimental Cancer Research (ISREC), Ecole Polytechnique Federale de Lausanne, Switzerland.
Prof. Qiang Liu MD | China
BC Surgeon, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University. Member of Asian Breast Cancer Collaborative Group (ABCCG)
Dr. Tal Sella MD | Israel
Head of the service for Young Women with Breast cancer. Medical Director of the Oncology Clinical Trials Department
Prof. Valentina Guarneri MD, PHD | Italy
Full Professor of Oncology at the University of Padova, and Director of the Master Degree programme in Clinical Research in Oncology.
Prof. Andreas Hartkopf MD | Germany
W3 Professorship Translationa Gynecologic Oncology and Medical Director of Research Center for Women's Health on Tuebingen University and Head of Medical Gynecologic Oncology Divison, Tuebingen Universtiy Hospital.
Provided by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
24 Oct 2024 To 24 Oct 2024 -
07:00 PM To 08:00 PM 
Certificate Available 
Online
- 9
Add to Calendar
10/24/2024 07:00 PM
10/24/2024 08:00 PM
Asia/ Riyadh
BC TALKS: “Optimising Treatment approaches for HR+/HER2- Early Breast Cancer”
BC TALKS: “Optimising Treatment approaches for HR+/HER2- Early Breast Cancer”
https://medicalacademy.org/portal/event/view/2271
